Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Immix Biopharma, Inc. (IMMX) had Tangible Shareholders Equity of $4.65M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.62M |
|
-- |
|
-- |
|
$6.72M |
|
$-6.72M |
|
$0.10M |
|
$-6.61M |
|
$-6.61M |
|
$-6.62M |
|
$-6.62M |
|
$-6.62M |
|
$-6.62M |
|
$-6.72M |
|
$-6.64M |
|
29.98M |
|
29.98M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$12.33M |
|
$2.23M |
|
$3.31M |
|
$15.64M |
|
$10.01M |
|
-- |
|
$0.97M |
|
$10.98M |
|
$4.65M |
|
|
Tangible Shareholders Equity |
$4.65M |
$4.65M |
|
28.41M |
|
| Cash Flow Statement Financials | |
$-6.99M |
|
$-0.20M |
|
$1.11M |
|
$17.68M |
|
$11.64M |
|
$-6.04M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-142.33% |
|
-142.33% |
|
-42.36% |
|
-142.33% |
|
$0.16 |
|
$-0.24 |
|
$-0.23 |
|